Recursion Pharmaceuticals has secured $239 million in new venture capital financing, plus a long-term collaboration deal with Bayer to help boost its pipeline...
Eight years ago, Two Sigma Investments began an experiment in early-stage investing. The hedge fund, focused on data-driven quantitative investing, was well on...